Comparison of evoked potentials across four related developmental encephalopathies

BACKGROUND: Developing biomarkers is a priority for drug development for all conditions, but vital in the rare neurodevelopmental disorders where sensitive outcome measures are lacking. We have previously demonstrated the feasibility and tracking of evoked potentials to disease severity in Rett synd...

Descripción completa

Detalles Bibliográficos
Autores principales: Saby, Joni N., Peters, Sarika U., Benke, Timothy A., Standridge, Shannon M., Swanson, Lindsay C., Lieberman, David N., Olson, Heather E., Key, Alexandra P., Percy, Alan K., Neul, Jeffrey L., Nelson, Charles A., Roberts, Timothy P. L., Marsh, Eric D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985257/
https://www.ncbi.nlm.nih.gov/pubmed/36870948
http://dx.doi.org/10.1186/s11689-023-09479-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985257/
https://www.ncbi.nlm.nih.gov/pubmed/36870948
http://dx.doi.org/10.1186/s11689-023-09479-9

Ejemplares similares